MRSN   $2.16  -1.37% Market Closed After Close 2.15 -0.46%

Mersana Therapeutics Inc
Total Cash 162.74M
totalCashPerShare 1.327
EBITDA -101.41M
Total Debt 32.93M
quickRatio 2.642
currentRatio 2.717
Total Revenue 29.94M
debtToEquity 390.803
Revenue/Share 0.247
ROA -0.26297
ROE -2.1333
grossProfits
freeCashflow -66.51M
operatingCashflow -132.56M
earningsGrowth
revenueGrowth -0.785
grossMargins -1.93807
ebitdaMargins 0.0
operatingMargins -11.10118
profitMargins 0.0
enterpriseValue 129.04M
forwardPE -3.0142856
floatShares 72.18M
sharesOutstanding 122.67M
sharesShort 10.28M
sharesShortPriorMonth 9.11M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.95%
Short Ratio help_outline 8.73%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 0.069
Price To Book help_outline 30.58
earningsQuarterlyGrowth
netIncomeToCommon -104.77M
trailingEps -0.85%
forwardEps -0.70%
enterpriseToEbitda -1.27
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.17 3Q 2024
institutionsCount 158
lastUpdated Sept. 16, 2024, 3:16 p.m.